Johnson & Johnson (JNJ) Tax Rate Growth (1y) (2010 - 2026)

Johnson & Johnson (JNJ) Tax Rate Growth (1y) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn -

Historic Data

Download Data
DateValue
Mar 29, 2026 -670.00
Dec 28, 2025 -1,475.00
Sep 28, 2025 1,195.00
Jun 29, 2025 -378.00
Mar 30, 2025 695.00
Dec 29, 2024 -265.00
Sep 29, 2024 189.00
Jun 30, 2024 373.00
Mar 31, 2024 -4,949.00
Dec 31, 2023 -1,664.00
Oct 1, 2023 74.00
Jul 2, 2023 -520.00
Apr 2, 2023 4,815.00
Oct 2, 2022 1,194.00
Jul 3, 2022 1,418.00
Apr 3, 2022 -288.00
Oct 3, 2021 -1,452.00
Jul 4, 2021 -221.00
Apr 4, 2021 563.00
Jan 3, 2021 -1,046.00